Search research articles
Contact Us
Filters
Showing results (341-350 of 471) with videos related to
Page
of 48
Sort By:
Neuropsychological Rehabilitation
|
April 21, 2019
Long-term neurobehavioural symptom reporting following mild, moderate, severe, and penetrating traumatic brain injury in U.S. military service members
Rael T Lange, Sara M Lippa, Louis M French, et al.
Leukemia
|
February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
N C P Cross, H E White, D Colomer, et al.
Der Orthopade
|
August 12, 2018
[The S2k guideline: Indications for knee endoprosthesis : Evidence and consent-based indications for total knee arthroplasty]
J Lützner, T Lange, J Schmitt, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Coordinated inheritance of extrachromosomal DNA species in human cancer cells
King L Hung, Matthew G Jones, Ivy Tsz-Lo Wong, et al.
Journal of Neurotrauma
|
November 26, 2025
Development of a Structured Interview for the American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain Injury
Rael T Lange, Kelly C Gillow, , et al.
Nature Genetics
|
September 19, 2022
The evolutionary dynamics of extrachromosomal DNA in human cancers
Joshua T Lange, John C Rose, Celine Y Chen, et al.
Bone Marrow Transplantation
|
September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens
M Deininger, W Pönisch, R Krahl, et al.
Oncotarget
|
March 3, 2016
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites
Robert J Allaway, Dawn A Fischer, Francine B de Abreu, et al.
Leukemia
|
January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
C Schütz, S Inselmann, S Saussele, et al.
Leukemia
|
January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
C Schütz, S Inselmann, S Saussele, et al.
Page
of 48
Search research articles
Search
Showing results (341-350 of 471) with videos related to
Sort By:
Page
of 48
Neuropsychological Rehabilitation
|
April 21, 2019
Long-term neurobehavioural symptom reporting following mild, moderate, severe, and penetrating traumatic brain injury in U.S. military service members
Rael T Lange, Sara M Lippa, Louis M French, et al.
Leukemia
|
February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
N C P Cross, H E White, D Colomer, et al.
Der Orthopade
|
August 12, 2018
[The S2k guideline: Indications for knee endoprosthesis : Evidence and consent-based indications for total knee arthroplasty]
J Lützner, T Lange, J Schmitt, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Coordinated inheritance of extrachromosomal DNA species in human cancer cells
King L Hung, Matthew G Jones, Ivy Tsz-Lo Wong, et al.
Journal of Neurotrauma
|
November 26, 2025
Development of a Structured Interview for the American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain Injury
Rael T Lange, Kelly C Gillow, , et al.
Nature Genetics
|
September 19, 2022
The evolutionary dynamics of extrachromosomal DNA in human cancers
Joshua T Lange, John C Rose, Celine Y Chen, et al.
Bone Marrow Transplantation
|
September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens
M Deininger, W Pönisch, R Krahl, et al.
Oncotarget
|
March 3, 2016
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites
Robert J Allaway, Dawn A Fischer, Francine B de Abreu, et al.
Leukemia
|
January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
C Schütz, S Inselmann, S Saussele, et al.
Leukemia
|
January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
C Schütz, S Inselmann, S Saussele, et al.
Page
of 48